iShares Biotechnology ETF (NASDAQ:IBB) Shares Acquired by Sculati Wealth Management LLC

Sculati Wealth Management LLC increased its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 21.0% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 11,530 shares of the financial services provider’s stock after buying an additional 2,004 shares during the period. Sculati Wealth Management LLC’s holdings in iShares Biotechnology ETF were worth $1,582,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in IBB. Blue Fin Capital Inc. raised its holdings in shares of iShares Biotechnology ETF by 0.7% in the second quarter. Blue Fin Capital Inc. now owns 10,516 shares of the financial services provider’s stock worth $1,443,000 after acquiring an additional 74 shares during the last quarter. Security National Bank of SO Dak increased its position in iShares Biotechnology ETF by 0.7% during the 2nd quarter. Security National Bank of SO Dak now owns 10,461 shares of the financial services provider’s stock worth $1,436,000 after purchasing an additional 75 shares in the last quarter. SPC Financial Inc. raised its stake in iShares Biotechnology ETF by 2.4% in the 3rd quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock valued at $475,000 after purchasing an additional 75 shares during the last quarter. Werba Rubin Papier Wealth Management lifted its holdings in iShares Biotechnology ETF by 2.7% in the 3rd quarter. Werba Rubin Papier Wealth Management now owns 2,918 shares of the financial services provider’s stock valued at $425,000 after purchasing an additional 76 shares in the last quarter. Finally, Main Street Financial Solutions LLC boosted its stake in shares of iShares Biotechnology ETF by 1.0% during the 2nd quarter. Main Street Financial Solutions LLC now owns 8,002 shares of the financial services provider’s stock worth $1,098,000 after purchasing an additional 82 shares during the last quarter. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ IBB opened at $140.10 on Thursday. iShares Biotechnology ETF has a 1 year low of $123.60 and a 1 year high of $150.57. The firm’s 50 day moving average price is $142.09 and its 200 day moving average price is $142.28.

iShares Biotechnology ETF Dividend Announcement

The company also recently announced a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were given a $0.2005 dividend. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.